• Skip to navigation (Press Enter).
  • Skip to main content (Press Enter).
  • Search
  • |
  • Sitemap
  • |
  • Legal Notice
  • |
  • Contact
  • Products
    • Product Lines
      • CellGro® Cytokines
        • Preclinical Grade for Preclinical Ex Vivo Use
        • GMP Grade for Clinical Ex Vivo Use
      • CellGro® Serum-free Media
      • Bioprocessing Containers
        • VueLife® Cell Culture Bags
        • VueLife® AC Cell Culture Bags
        • KyroSure® Freezing Bags
        • Overwraps
        • Tubing Sets
        • Accessoires
      • GMP Cell Products
        • CartiGro®
    • Products by Cell Types
      • Dendritic Cells
      • Hematopoietic Stem and Progenitor Cells
      • Natural Killer Cells
      • T-Cells
      • Mesenchymal Stem Cells
      • Chondrocytes
      • Embryonic Stem Cells and Induced Pluripotent Stem Cells
  • |
  • Research & Development
  • |
  • Company
    • Our Vision & Commitment
    • Management
    • Supervisory Board
    • Contact & Customer Service
      • CellGenix Worldwide
      • Customer Service & Regulatory Support
    • Partners
      • Distributors Ex Vivo Therapeutics
      • Cooperations & Alliances
    • Jobs & Careers
  • |
  • Regulatory Support
    • Quality Standards
    • ADCF & Serum-free Policy
    • DMF Service
  • |
  • Downloads
    • Catalog, Brochure
    • Product Order Information
    • Product Data Sheets
    • Product References
    • Useful Information & FAQ
    • Contact & Order Form
  • |
  • News & Events
    • News
    • Exhibitions
    • Press Releases
 
Home » News & Events » Press Releases » Press Releases: Archive
Contact & Order Form

Press Releases: Archive

Freiburg, June 05, 2005
CellGenix registers FDA Drug Master Files for CellGro® TNF-alpha and GM-CSF

Freiburg, December 01, 2004
CellGenix feiert zehnten Jahrestag der Gründung

Freiburg, November 18, 2004
CellGenix receives EU- orphan drug status for IdioVax® cancer vaccine

Freiburg, October 15, 2003
CellGenix files first FDA Drug Master File for CellGro® IL-4

Go back to: » Press Releases

 
Copyright © 2012 CellGenix GmbH